Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, GA, USA; Denver Public Health, Denver Health and Hospital Authority, Denver, CO, USA.
Denver Public Health, Denver Health and Hospital Authority, Denver, CO, USA.
Drug Alcohol Depend. 2021 Jan 1;218:108306. doi: 10.1016/j.drugalcdep.2020.108306. Epub 2020 Sep 21.
The national and state economic burden of the opioid crisis is substantial. This study estimated the number of hospitalizations associated with opioid use disorder (OUD) or opioid misuse (OM) and the cost of those hospitalizations at Denver Health (DH) Medical Center, a large, urban safety-net hospital.
For 2017, direct inpatient medical costs for hospitalizations associated with OUD or OM at DH Medical Center were estimated and categorized by group and insurance type. Data were from the DH electronic health records database that included charge data. Hospitalizations associated with OUD or OM were identified using diagnostic codes and an expanded set of inclusion criteria including diagnostic codes, opioid withdrawal assessments, opioid-related admission notes, and medication prescriptions to treat OUD. Costs were estimated using cost-to-charge ratios specific to DH.
During 2017, 220 hospitalizations, $9,834,979 in total charges, $3,690,724 in estimated total costs, and $2,115,990 in total reimbursements were identified using diagnostic codes. Using the most expansive set of inclusion criteria, 739 hospitalizations, $35,033,157 in total charges, $13,346,099 in estimated total costs, and $7,020,877 in total reimbursements were identified. Of the 739 hospitalizations, Medicaid covered 546 hospitalizations (74 %), the largest proportion of total reimbursement (65 %), with estimated total costs of $10,135,048 (77 %).
Our study identified considerable costs for hospitalizations associated with OUD or OM for DH. Estimating costs for hospitalizations associated with OUD or OM through use of expanded inclusion methodology can guide future program planning to allocate resources efficiently for hospitals such as DH Medical Center.
阿片类药物危机给国家和州带来了巨大的经济负担。本研究旨在评估丹佛健康医疗中心(DHMC)因阿片类药物使用障碍(OUD)或阿片类药物滥用(OM)住院的人数和住院费用,该中心是一家大型城市医疗保障医院。
对于 2017 年,DHMC 因 OUD 或 OM 住院的直接住院医疗费用进行了估计,并按组别和保险类型进行了分类。数据来源于 DHMC 的电子健康记录数据库,包括收费数据。使用诊断代码和一套扩展的纳入标准(包括诊断代码、阿片类药物戒断评估、与阿片类药物相关的入院记录和治疗 OUD 的药物处方)来确定与 OUD 或 OM 相关的住院。使用特定于 DH 的成本与收费比来估计成本。
2017 年,使用诊断代码共确定了 220 例住院,总收费 9834979 美元,估计总费用 3690724 美元,总报销 2115990 美元。使用最广泛的纳入标准,共确定了 739 例住院,总收费 35033157 美元,估计总费用 13346099 美元,总报销 7020877 美元。在这 739 例住院中,有 546 例(74%)由医疗补助支付,占总报销的最大比例(65%),估计总费用为 10135048 美元(77%)。
我们的研究确定了 DH 因 OUD 或 OM 住院的巨大费用。通过使用扩展的纳入方法来估计 OUD 或 OM 住院的费用,可以为 DHMC 等医院的未来规划方案提供指导,以便有效地分配资源。